Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lung Valve Device Wins Medicare Inpatient Add-On Payment

This article was originally published in The Gray Sheet

Executive Summary

The Spiration IBV Valve System is the only product to gain a new technology add-on payment from CMS under the 2010 inpatient prospective payment system rule released July 31

You may also be interested in...



Waiting For Exhale: Emphysema Researchers Call For New Stent Designs, More Analysis

New stent designs and placement techniques are needed to develop an interventional device that successfully treats severe emphysema, researchers said following publication of disappointing study results for a drug-eluting stent system intended to create airway passages in the lung.

Waiting For Exhale: Emphysema Researchers Call For New Stent Designs, More Analysis

New stent designs and placement techniques are needed to develop an interventional device that successfully treats severe emphysema, researchers said following publication of disappointing study results for a drug-eluting stent system intended to create airway passages in the lung.

CMS Awards Monteris Add-On Payment For Tumor Ablation Catheter

Monteris Medical expects to deploy its AutoLITT tumor ablation catheter to the market "slowly and methodically" following a favorable Medicare reimbursement decision, according to Jim Duncan, the firm's CEO

Related Content

Topics

UsernamePublicRestriction

Register

OM006664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel